Position in AVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,367,559
+$25,767,570 QoQ
Shares Held
1,913,829
+197.6% QoQ
Ownership
3.57%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 126 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. AVTX ranks #62 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in AVTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,367,559 | 1,913,829 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,599,989 | 643,000 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $11,283,715 | 621,350 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,700,251 | 605,842 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,028,788 | 406,571 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $45,440 | 5,673 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $42,128 | 5,670 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $53,209 | 5,601 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $69,844 | 5,601 | Shares | Defined | 2024-08-14 | |
| 2023-06-30 | $1,465 | 4,127 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,539 | 4,308 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $50 | 10 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $13 | 4 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24 | 52 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,723 | 3,758 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $46,165 | 27,157 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $102,066 | 46,820 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 CERC | — | 4,997 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 CERC | — | 31,744 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 CERC | — | 10,804 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 CERC | — | 3,311 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 CERC | — | 7,373 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 CERC | — | 3,990 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||